甲对老鼠CKD诱导的认知功能障碍的神经保护作用:CBS和Nrf2/HO-1通路的作用
Zeinab Hamidizad1,2, Mehri Kadkhodaee3, Farzaneh Kianian3
1Electrophysiology Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Neuromolecular medicine
|January 8, 2025
概括
氧化 (NO) 有效治疗老鼠慢性病 (CKD) 引起的认知缺陷和神经元损伤. 这些好处取决于囊氨酸β合成酶 (CBS) 活性和硫化 (H2S) 水平.
科学领域:
- 神经科学是一个神经科学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物化学 生化学
背景情况:
- 慢性病 (CKD) 与认知障碍和痴呆症有关.
- 尿素毒素,氧化应激和炎症是CKD相关神经系统疾病的关键媒介.
- 氧化 (NO) 在神经元信号传递和细胞内通路中起着至关重要的作用.
研究的目的:
- 研究NO在缓解与CKD相关的认知缺陷方面的治疗潜力.
- 探索核因子-红色素因子2相关因子2 (Nrf2) /血氧酶-1 (HO-1) 途径和囊氨酸β-合成酶 (CBS) 在NO的影响中的参与.
主要方法:
- 建立了一种CKD (5/6腎切除术) 的老鼠模型.
- 这些组包括假药,CKD,CKD + NO捐赠体 (SNP) 和CKD + SNP + CBS抑制剂 (AOAA).
- 用行为测试评估认知功能; 生物化学和组织学分析评估神经元损伤和通路活动.
主要成果:
- 慢性结核病的老鼠表现出显著的认知衰退,增加了血液尿素 (BUN) 和血清肌素 (sCr),以及神经元损伤.
- 慢性瘤还降低了海马和前额叶皮层中的Nrf2/HO-1通路活性.
- SNP治疗改善了认知功能,减少了神经元损伤,并恢复了Nrf2/HO-1活性,但这些效应被CBS抑制剂消除了.
结论:
- 氧化 (NO) 在改善慢性瘤的认知障碍和神经元损伤方面表现出显著的有效性.
- 的神经保护作用取决于氨酸β合成酶 (CBS) 的活性和内源硫化 (H2S) 的产生.
- 针对NO-CBS-H2S轴可能提供一种新的治疗策略,用于治疗慢性病患者的神经并发症.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95
Antihypertensive Drugs: Vasodilators
473
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
473
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K


